When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
TCDA - FDA rejects Tricida's veverimer for metabolic acidosis in CKD patients
Tricida Inc.
Tricida (TCDA-14.5%) has received a Complete Response Letter (CRL) from the FDA regarding its marketing application seeking approval of veverimer (TRC101) for metabolic acidosis in patients with chronic kidney disease (CKD).
More news on: Tricida, Inc., Healthcare stocks news, Stocks on the move,